The FINANCIAL -- Abbott Japan Co., Ltd. and Eisai Co., Ltd. announced today that they have submitted an application in Japan seeking approval of inhibition of structural damage of joints in rheumatoid arthritis as an additional indication for Humira® (adalimumab; recombinant) Pre-filled Syringe 40 mg/0.8 mL, a fully human anti-TNF-α monoclonal antibody jointly developed by the two companies.

The FINANCIAL -- MADISON, NJ—Bausch + Lomb, the global eye health company, has added a new product to its signature loteprednol etabonate line: LOTEMAX® Ointment.

The FINANCIAL -- Chennai/Singapore-26 September 2011: Fitch ratings has assigned Ogene Systems India Private Limited a National Long-Term rating of 'Fitch B+(ind)'.

The FINANCIAL -- Monheim, September 26, 2011 – Bayer CropScience AG and Evogene Ltd. have reached a milestone in their joint research collaboration in wheat.

The FINANCIAL -- Bayer HealthCare Pharmaceuticals today announced positive data on its investigational drug Alpharadin  from the Phase III ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) trial.